The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: A population-based study in Taiwan over a 25-year period (1979-2003)

Annals of Oncology

Volumn 19, Issue 6, 2008, Pages 1180-1186

  Chen, M C ^a   Feng, I J ^b   Lu, C H ^c,d   Chen, C C ^c,d   Lin, J T ^c,d   Huang, S H ^a   Lee, K D ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Cumulative incidence; Nasopharyngeal carcinoma; Second primary cancer

Indexed keywords

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALIVARY GLAND CANCER; SARCOMA; SECOND CANCER; SKIN CANCER; SURVIVAL TIME; TAIWAN;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; TAIWAN;

EID: 44849117824     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn003     Document Type: Article

References (25)

1. Jia WH, Huang QH, Liao J et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer 2006; 6: 178.
2. Lee AW, Foo W, Mang O et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality. Int J Cancer 2003; 103: 680-685.
3. Lin JC, Chen KY, Wang WY et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 2001; 19: 2607-2615.
4. Lin JC, Wang WY, Chen KY et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350: 2461-2470.
5. Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: Report of a case-control study in Hong Kong. Cancer Res 1986; 46: 956-961.
6. Sriamporn S, Vatanasapt V, Pisani P et al. Environmental risk factors for nasopharyngeal carcinoma: A case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev 1992; 1: 345-348.
7. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983; 43: 2967-2970.
8. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 1990; 82: 291-296.
9. Feng BJ, Huang W, Shugart YY et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002; 31: 395-399.
10. Xiong W, Zeng ZY, Xia JH et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64: 1972-1974.
11. Cancer Registry Annual Report. Taiwan, R.O.C: Department of Health 2001.
12. Jones AS, Morar P, Phillips DE et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75: 1343-1353.
13. Day GL, Blot WJ, Shore RE et al. Second cancers following oral and pharyngeal cancer: Patients' characteristics and survival patterns. Eur J Cancer B Oral Oncol 1994; 30B: 381-386.
14. Choy AT, van Hasselt CA, Chisholm EM et al. Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck. Cancer 1992; 70: 815-820.
15. Teshima T, Inoue T, Chatani M et al. Incidence of other primary cancers in 1,569 patients with pharyngolaryngeal cancer and treated with radiation therapy. Strahlenther Onkol 1992; 168: 213-218.
16. Wang CC, Chen ML, Hsu KH et al. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus. Int J Cancer 2000; 87: 228-231.
17. Cooper JS, Scott C, Marcial V et al. The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy Oncology Group experience. Cancer 1991; 67: 1673-1677.
18. Scelo G, Boffetta P, Corbex M et al. Second primary cancers in patients with nasopharyngeal carcinoma: A pooled analysis of 13 cancer registries. Cancer Causes Control 2007; 18: 269-278.
19. Slee VN. The International Classification of Diseases: Ninth revision (ICD-9). Ann Intern Med 1978; 88: 424-426.
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 1987; 1-406.
21. Kalbfleisch JD, Prentice R. The Analysis of Failure Time Data. New York, NY: John Wiley 1980.
22. Gary R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
23. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 421-429.
24. Kong L, Lu JJ, Hu C et al. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer 2006; 107: 1287-1293.
25. Alberts DS. Second cancers are killing us!. Cancer Epidemiol Biomarkers Prev 2006; 15: 2019.